latest news releases from the newsroom
Capital Research Group, Inc
Hot Stocks To Watch for Friday, August 13, 2004: MOVN, NTAP, SEBL, ATML
WESTON, Fla., Aug. 13, 2004 (PRIMEZONE) -- TheSUBWAY.com names the following stocks to its Stock Watch List: MotivNation Inc. (OTCBB:MOVN), Network Appliance Inc. (Nasdaq:NTAP), Siebel Systems Inc. (Nasdaq:SEBL), Atmel Corporation (Nasdaq:ATML).
Medivir and Novartis Resolve Issue of Partly Overlapping Patents in USA
HUDDINGE, Sweden, Aug. 13, 2004 (PRIMEZONE) -- Medivir and Novartis have resolved the issue of partly overlapping patents in the USA relating to the Medivir ME-609 project by means of a free, two-way licence agreement. This agreement gives Medivir exclusive rights to topical combination products containing the antiviral agent acyclovir, such as ME-609, or omaciclovir (H2G), Medivir's antiviral substance. Novartis is granted a non-exclusive licence to certain antiviral combination products such as penciclovir, while Medivir will retain the exclusive rights to its formulation patent relating to combinations containing penciclovir. In countries outside of the USA, including the EU, there is no conflict between the Medivir and Novartis patents.
Much Shelist Freed Denenberg Ament & Rubenstein
Investors in Red Hat, Inc. have until September 13, 2004 to File Lead Plaintiff Petitions, says Chicago Law Firm Much Shelist -- RHAT
CHICAGO, Aug. 12, 2004 (PRIMEZONE) -- The deadline for purchasers of the securities of Red Hat ("Red Hat" or the "Company") (Nasdaq:RHAT) to move for lead plaintiff in a securities fraud class action brought by Much Shelist against Red Hat and certain of its officers and directors is rapidly approaching. If you purchased Red Hat securities between December 18, 2003 and July 12, 2004, inclusive ("Class Period") and you wish to be a lead plaintiff in the case, you must move to serve as lead plaintiff by filing a motion in the United States District Court for the Eastern District of North Carolina by September 13, 2004.